Patents by Inventor Chin-Yao Yang

Chin-Yao Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Magnetic tunnel junction (MTJ) device and forming method thereof
    Patent number: 11950431
    Abstract: A magnetic tunnel junction (MTJ) device includes two magnetic tunnel junction elements and a magnetic shielding layer. The two magnetic tunnel junction elements are arranged side by side. The magnetic shielding layer is disposed between the magnetic tunnel junction elements. A method of forming said magnetic tunnel junction (MTJ) device includes the following steps. An interlayer including a magnetic shielding layer is formed. The interlayer is etched to form recesses in the interlayer. The magnetic tunnel junction elements fill in the recesses. Or, a method of forming said magnetic tunnel junction (MTJ) device includes the following steps. A magnetic tunnel junction layer is formed. The magnetic tunnel junction layer is patterned to form magnetic tunnel junction elements. An interlayer including a magnetic shielding layer is formed between the magnetic tunnel junction elements.
    Type: Grant
    Filed: December 2, 2022
    Date of Patent: April 2, 2024
    Assignee: UNITED MICROELECTRONICS CORP.
    Inventors: Wei Chen, Hui-Lin Wang, Yu-Ru Yang, Chin-Fu Lin, Yi-Syun Chou, Chun-Yao Yang
  • Stacking Via Structures for Stress Reduction
    Publication number: 20240088061
    Abstract: A method includes forming a first dielectric layer, forming a first redistribution line comprising a first via extending into the first dielectric layer, and a first trace over the first dielectric layer, forming a second dielectric layer covering the first redistribution line, and patterning the second dielectric layer to form a via opening. The first redistribution line is revealed through the via opening. The method further includes forming a second via in the second dielectric layer, and a conductive pad over and contacting the second via, and forming a conductive bump over the conductive pad. The conductive pad is larger than the conductive bump, with a first center of conductive pad being offsetting from a second center of the conductive bump. The second via is further offset from the second center of the conductive bump.
    Type: Application
    Filed: November 22, 2023
    Publication date: March 14, 2024
    Inventors: Shu-Shen Yeh, Che-Chia Yang, Chin-Hua Wang, Po-Yao Lin, Shin-Puu Jeng, Chia-Hsiang Lin
  • KINASE INHIBITOR SALTS AND COMPOSITIONS THEREOF
    Publication number: 20230142737
    Abstract: The present invention relates to cabozantinib lauryl sulfate salt and methods of use.
    Type: Application
    Filed: January 13, 2023
    Publication date: May 11, 2023
    Applicant: Handa Oncology, LLC
    Inventors: FANG-YU LIU, K. C. SUNG, CHIN-YAO YANG, CHI-CHENG LIN, YI-HSIN LIN, LI QIAO
  • Kinase inhibitor salts and compositions thereof
    Patent number: 11160805
    Abstract: The present invention relates to kinase inhibitor C8-C16 aliphatic sulfate salts, compositions containing kinase inhibitor C8-C16 aliphatic sulfate salts and uses thereof.
    Type: Grant
    Filed: February 24, 2020
    Date of Patent: November 2, 2021
    Assignee: HANDA ONOCOLOGY, LLC
    Inventors: Fang-Yu Liu, K. C. Sung, Chin-Yao Yang, Chi-Cheng Lin, Yi-Hsin Lin, Li Qiao
  • KINASE INHIBITOR SALTS AND COMPOSITIONS THEREOF
    Publication number: 20210283133
    Abstract: The present invention relates to capsules comprising dasatinib lauryl sulfate salt.
    Type: Application
    Filed: May 17, 2021
    Publication date: September 16, 2021
    Applicant: HANDA ONCOLOGY, LLC
    Inventors: FANG-YU LIU, K.C. SUNG, CHIN-YAO YANG, CHI-CHENG LIN, YI-HSIN LIN, LI QIAO
  • Kinase inhibitor salts, and compositions thereof
    Patent number: 11052088
    Abstract: The present invention relates to polymorphic forms of dasatinib lauryl sulfate salt.
    Type: Grant
    Filed: February 4, 2021
    Date of Patent: July 6, 2021
    Assignee: Handa Oncology, LLC
    Inventors: Fang-Yu Liu, K. C. Sung, Chin-Yao Yang, Chi-Cheng Lin, Yi-Hsin Lin, Li Qiao
  • KINASE INHIBITOR SALTS, AND COMPOSITIONS THEREOF
    Publication number: 20210161895
    Abstract: The present invention relates to polymorphic forms of dasatinib lauryl sulfate salt.
    Type: Application
    Filed: February 4, 2021
    Publication date: June 3, 2021
    Applicant: Handa Oncology, LLC
    Inventors: FANG-YU LIU, K.C. SUNG, CHIN-YAO YANG, CHI-CHENG LIN, YI-HSIN LIN, LI QIAO
  • Kinase inhibitor salts, and compositions thereof
    Patent number: 11007195
    Abstract: The present invention relates to kinase inhibitor C8-C16 aliphatic sulfate salts, compositions containing kinase inhibitor C8-C16 aliphatic sulfate salts and uses thereof.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: May 18, 2021
    Assignee: HANDA ONCOLOGY, LLC
    Inventors: Fang-Yu Liu, K.C. Sung, Chin-Yao Yang, Chi-Cheng Lin, Yi-Hsin Lin, Li Qiao
  • Kinase inhibitor salts and compositions thereof
    Patent number: 10940149
    Abstract: The present invention relates to polymorphic forms of nilotinib lauryl sulfate salt.
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: March 9, 2021
    Assignee: HANDA ONCOLOGY, LLC
    Inventors: Fang-Yu Liu, K. C. Sung, Chin-Yao Yang, Chi-Cheng Lin, Yi-Hsin Lin, Li Qiao
  • KINASE INHIBITOR SALTS AND COMPOSITIONS THEREOF
    Publication number: 20210046077
    Abstract: The present invention relates to polymorphic forms of nilotinib lauryl sulfate salt.
    Type: Application
    Filed: October 30, 2020
    Publication date: February 18, 2021
    Applicant: HANDA PHARMACEUTICALS, LLC
    Inventors: FANG-YU LIU, K.C. SUNG, CHIN-YAO YANG, CHI-CHENG LIN, YI-HSIN LIN, LI QIAO
  • KINASE INHIBITOR SALTS AND COMPOSITIONS THEREOF
    Publication number: 20200188400
    Abstract: The present invention relates to kinase inhibitor C8-C16 aliphatic sulfate salts, compositions containing kinase inhibitor C8-C16 aliphatic sulfate salts and uses thereof.
    Type: Application
    Filed: February 24, 2020
    Publication date: June 18, 2020
    Applicant: HANDA PHARMACEUTICALS, LLC
    Inventors: FANG-YU LIU, K.C. SUNG, CHIN-YAO YANG, CHI-CHENG LIN, YI-HSIN LIN, LI QIAO
  • KINASE INHIBITOR SALTS, AND COMPOSITIONS THEREOF
    Publication number: 20200113903
    Abstract: The present invention relates to kinase inhibitor C8-C16 aliphatic sulfate salts, compositions containing kinase inhibitor C8-C16 aliphatic sulfate salts and uses thereof.
    Type: Application
    Filed: December 3, 2019
    Publication date: April 16, 2020
    Applicant: HANDA PHARMACEUTICALS, LLC
    Inventors: FANG-YU LIU, K.C. SUNG, CHIN-YAO YANG, CHI-CHENG LIN, YI-HSIN LIN, LI QIAO
  • Release stable mesalamine dosage forms
    Patent number: 10098898
    Abstract: Solid oral mesalamine delayed/controlled release tablets with storage stable dissolution profiles are described.
    Type: Grant
    Filed: December 4, 2017
    Date of Patent: October 16, 2018
    Assignee: HANDA PHARMACEUTICALS, LLC
    Inventors: K. C. Sung, Chi-Cheng Lin, Chin-Yao Yang, Fang-Yu Liu